HAMBURG, Germany, Jan. 13, 2011 (GLOBE NEWSWIRE) — Evotec AG (Frankfurt:EVT) today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 2.0 million to Evotec. The milestone reached was on the transition of an oncology programme into lead optimisation.
Dr Mario Polywka, Chief Operating Officer of Evotec commented: [...] http://bit.ly/glBMEy
No comments:
Post a Comment